| SATURDAY, MARCH 25, 2023 | HALL A | |
 | |
| 13:30-14:30 | Bayer Sponsored Symposium Have we maximised outcomes for our patients, or can we go further with disease control? (Dessert boxes served 13:15 -13:30) |
| Co-chairs: | Ângela Carneiro, Portugal Anat Loewenstein, Israel |
| 13:30 | Welcome and introductions Ângela Carneiro, Portugal |
| 13:35 | Have we maximised outcomes for our patients? Marion Munk, Switzerland |
| 13:45 | Will targeting new pathways lead to improvements in efficacy outcomes? Michael Stewart, USA |
| 13:55 | Is aflibercept 8mg a game changer? Anat Loewenstein, Israel |
| 14:10 | Panel discussion All |
| 14:25 | Summary of key learnings Ângela Carneiro, Portugal |
